Physician profile
Stephen Beck
NPI 1881612612
$17,713.38
in general payments reported to CMS, 2019-2025
81 companies · $2,864 in 2025
The $2,864 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,163 · 2020: $1,255 · 2021: $2,132 · 2022: $3,024 · 2023: $3,007 · 2024: $3,269 · 2025: $2,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,910 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,909.62 |
| Education | $229.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,031.14 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,074.95 | 2019-2025 | Keytruda, Lynparza, Welireg |
| E.R. Squibb & Sons, L.L.C. | $1,013.00 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Astrazeneca Pharmaceuticals Lp | $932.53 | 2019-2025 | Enhertu, Imfinzi, Calquence |
| Janssen Biotech, INC. | $885.59 | 2019-2025 | Darzalex, Talvey, Erleada |
| Eisai INC. | $671.88 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $654.64 | 2019-2025 | Ninlaro, Fruzaqla, Iclusig |
| Celgene Corporation | $653.96 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Daiichi Sankyo INC. | $600.97 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Amgen INC. | $587.99 | 2019-2023 | Blincyto |
| Abbvie INC. | $580.49 | 2021-2025 | Venclexta |
| Seagen INC. | $537.94 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Ipsen Biopharmaceuticals, INC | $459.88 | 2019-2024 | Onivyde, Somatuline Depot |
| Beigene USA, INC. | $399.20 | 2020-2025 | Brukinsa, Tevimbra |
| Pfizer INC. | $382.53 | 2019-2024 |
Show all 81 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $341.39 | 2022-2025 | |
| Incyte Corporation | $324.46 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Genentech USA, INC. | $296.81 | 2019-2025 | Polivy, Columvi, Lunsumio |
| Genzyme Corporation | $285.58 | 2021-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $240.36 | 2019-2023 | Imbruvica, Epkinly |
| Deciphera Pharmaceuticals INC. | $240.34 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Lilly USA, LLC | $223.46 | 2019-2024 | Jaypirca, Verzenio, Retevmo |
| Karyopharm Therapeutics INC. | $221.59 | 2020-2025 | Xpovio |
| Alexion Pharmaceuticals, INC. | $219.24 | 2019-2024 | Ultomiris, Soliris |
| Glaxosmithkline, LLC. | $218.74 | 2019-2025 | Jemperli, Ojjaara, Zejula |
| Stemline Therapeutics INC. | $163.59 | 2023-2025 | Orserdu |
| Bayer Healthcare Pharmaceuticals INC. | $150.06 | 2019-2025 | |
| Tesaro, INC. | $145.00 | 2019 | |
| Beone Medicines USA, INC. | $144.31 | 2025 | Tevimbra, Brukinsa |
| Gilead Sciences, INC. | $142.64 | 2021-2025 | Trodelvy |
| Springworks Therapeutics, INC. | $135.64 | 2024-2025 | Ogsiveo |
| Regeneron Healthcare Solutions, INC. | $126.56 | 2019-2025 | Libtayo |
| Myriad Genetic Laboratories, INC. | $119.97 | 2021-2022 | |
| Kite Pharma, INC. | $116.96 | 2021-2025 | Yescarta |
| Adc Therapeutics America, INC. | $111.03 | 2023-2025 | |
| Immunocore Limited | $99.90 | 2025 | Kimmtrak |
| Octapharma USA, INC. | $97.01 | 2020 | |
| Sumitomo Pharma America, INC. | $91.84 | 2023-2024 | Orgovyx |
| Astellas Pharma US INC | $91.60 | 2019-2025 | Xtandi, Vyloy |
| Epizyme, INC. | $90.37 | 2020-2021 | |
| Genmab U.S., INC. | $87.43 | 2023-2025 | Epkinly |
| Aveo Pharmaceuticals, INC. | $87.29 | 2021-2025 | |
| Immunogen, INC. | $84.57 | 2023-2024 | Elahere, Elahere |
| Pharmaessentia USA Corporation | $81.09 | 2023-2024 | Besremi |
| Puma Biotechnology, INC. | $77.85 | 2021-2023 | |
| Exelixis INC. | $77.47 | 2019-2025 | Cabometyx |
| Array Biopharma INC | $69.94 | 2021-2025 | Mektovi, Tukysa, Braftovi |
| Iovance Biotherapeutics, INC. | $67.86 | 2024-2025 | Amtagvi |
| Servier Pharmaceuticals LLC | $65.02 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $62.96 | 2021-2024 | Zepzelca |
| Taiho Oncology, INC. | $61.51 | 2019-2025 | |
| Emd Serono, INC. | $54.32 | 2019-2025 | |
| Recordati_rare_diseases_inc. | $52.13 | 2025 | Enjaymo, Sylvant |
| Pharming Healthcare, INC. | $49.18 | 2023-2025 | Ruconest |
| Dendreon Pharmaceuticals LLC | $48.78 | 2019-2025 | Provenge |
| Kyowa Kirin, INC. | $48.14 | 2019-2020 | |
| Pharmacosmos Therapeutics INC. | $47.71 | 2021-2022 | |
| Tersera Therapeutics LLC | $47.68 | 2019 | |
| Fennec Pharmaceuticals, INC. | $46.31 | 2025 | Fyarro |
| Coherus Oncology, INC. | $44.71 | 2024-2025 | Loqtorzi |
| Agios Pharmaceuticals, INC. | $43.67 | 2024-2025 | Pyrukynd |
| Shield Therapeutics INC | $39.54 | 2023-2024 | Accrufer |
| Acrotech Biopharma INC. | $37.45 | 2021-2022 | |
| Csl Behring | $37.03 | 2022 | |
| Janssen Pharmaceuticals, INC | $36.98 | 2020-2021 | |
| Cti Biopharma Corp. | $36.93 | 2022-2023 | Vonjo |
| Secura Bio, INC. | $35.59 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $35.19 | 2021 | |
| Mirati Therapeutics, INC. | $31.24 | 2023-2024 | Krazati |
| Verastem, INC. | $26.99 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.08 | 2020 | |
| Eusa Pharma (US) LLC | $20.68 | 2022 | |
| Innate Pharma, INC | $17.76 | 2020 | |
| Global Blood Therapeutics, INC. | $17.13 | 2022 | |
| Blueprint Medicines Corporation | $16.79 | 2023 | Ayvakit |
| Aurobindo Pharma USA, INC. | $16.79 | 2020 | |
| Dova Pharmaceuticals | $16.26 | 2019 | |
| Rigel Pharmaceuticals, INC. | $15.60 | 2022 | |
| Telix Pharmaceuticals | $15.25 | 2023 | Illuccix |
| Acceleron Pharma, INC. | $14.44 | 2021 | |
| Adaptive Biotechnologies Corporation | $13.90 | 2023 | Clonoseq |
Drugs and devices associated with these payments
Enhertu $637Keytruda $516Kisqali $389Brukinsa $337Venclexta $293Lynparza $249Imbruvica $236Reblozyl $226Epkinly $226Lenvima $220Scemblix $203Ninlaro $201Pluvicto $191Elahere $190Fruzaqla $189Qinlock $187Orserdu $164Imfinzi $159Sarclisa $157Tukysa $152Opdivo $144Jakafi $142Ogsiveo $136Adcetris $132Vonjo $130Orgovyx $128Calquence $124Polivy $119Onivyde $117Somatuline Depot $117Doptelet $110Tevimbra $108Monjuvi $103Pemazyre $103Kimmtrak $99.90Jaypirca $98.36Libtayo $97.47Tasigna $94.21Welireg $85.53Columvi $83.39Lunsumio $83.39Darzalex $82.23Besremi $81.09Fabhalta $78.19Verzenio $77.91Xpovio $69.97Xtandi $69.22Pomalyst $68.61Ultomiris $68.31Amtagvi $67.86Cabometyx $60.70Tecentriq $60.41Opdualag $60.31Romvimza $57.67Soliris $56.31Jemperli $55.20Promacta $53.53Retevmo $53.13Fotivda $51.89Inqovi $49.20Lonsurf $49.20Ruconest $49.18Yescarta $48.59Talvey $48.57Lutathera $47.88Elrexfio $46.98Fyarro $46.31Krazati $44.46Pyrukynd $43.67Injectafer $43.37Gamifant $43.27Ibrance $42.92Tivdak $42.78Stivarga $42.04Nubeqa $42.04Zynlonta $39.90Accrufer $39.54Ojjaara $39.03Balversa $37.14Erleada $37.14Akeega $37.14Padcev $36.53Piqray $35.46Voranigo $35.18Zepzelca $34.79Trodelvy $34.11Tecvayli $33.66Provenge $32.95Tgct $31.86Illuccix $30.50Enjaymo $30.39Tibsovo $29.84Mekinist $28.21Vitrakvi $26.88Udenyca $23.81Datroway $23.28Mektovi $23.07Braftovi $23.07Iclusig $22.36Sylvant $21.74
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.